Martek
This article was originally published in The Tan Sheet
Executive Summary
Manufacturer of docosahexaenoic acid (DHA) products is test marketing a chewable form of the fatty acid beginning in early August, the company announces July 26. Martek currently markets the Neuromins DHA line, which includes a standard formula, Neuromins PL for pregnant and lactating women and an extension for children. The Columbia, Md.-based firm awaits an FDA response to its GRAS notification to add DHA to infant formula
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning